No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditions
|
- |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D01
- Name in latin
- Carcinoma in situ hepatis
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of rectum
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of rectum
- Carcinoma in situ of other and unspecified digestive organs
- Carcinoma in situ of other and unspecified digestive organs
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 174 | 86 | 84 |
| Only index persons | 103 | 52 | 51 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 71.50 | 70.93 | 71.69 |
| Only index persons | 70.19 | 69.41 | 70.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 262 | 108 | 154 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.07 |
| Median age at first event (years) | 70.09 | 69.02 | 70.83 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 233
- Matched controls
- 2328
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
89.8
136.0
148
44
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
62.7
131.7
157
74
8263/2-C20.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS
+∞
105.4
93
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
70.5
64
*
C209, 8211, 2
ICD-O-3
NA
+∞
61.2
56
*
WX402
NOMESCO Finland
General anaesthesia
12.4
53.4
110
157
C209, 8148, 2
ICD-O-3
NA
+∞
53.2
49
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
49.8
46
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
39.7
49.4
62
21
UJF32
NOMESCO Finland
Coloscopy
8.1
46.4
141
370
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
43.1
40
*
130
Kela drug reimbursment
Malignant tumour
+∞
42.0
39
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
247.4
41.3
41
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
21.7
38.9
58
35
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
14.7
32.9
57
50
B01AB05
ATC
enoxaparin; parenteral
5.3
29.7
121
394
L01BC06
ATC
capecitabine; oral
+∞
28.7
27
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
27.7
26
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
27.7
26
*
JFF23
NOMESCO Finland
Transversostomy
151.9
26.2
27
*
JGA73
NOMESCO Finland
Transanal excision of lesion of rectum
145.6
25.1
26
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
23.3
22
*
TPH07
NOMESCO Finland
Cathetrisation of artery
8.0
23.2
56
89
UJG02
NOMESCO Finland
Proctoscopy
27.3
22.9
31
13
JN4AD
NOMESCO Finland
Body CT examination
14.9
22.1
37
29
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
20.1
19
*
WF002
NOMESCO Finland
Radical radiotherapy
114.9
19.9
21
*
WX600
NOMESCO Finland
Single shot through catheter
114.9
19.9
21
*
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
76.4
19.0
21
*
JN4BD
NOMESCO Finland
Extensive body CT
9.1
17.7
38
49
H02AB02
ATC
dexamethasone; systemic
24.1
17.3
24
11
B01AB10
ATC
tinzaparin; parenteral
9.8
16.7
34
40
R4110
NOMESCO Finland
Physiotherapy
3.7
16.6
92
350
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.1
15.9
23
12
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
15.8
15
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
+∞
15.8
15
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
7.2
15.4
38
61
A04AA01
ATC
ondansetron; systemic, rectal
20.1
15.0
22
12
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
14.7
14
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
14.7
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.7
14
*
JGA75
NOMESCO Finland
Endoscopic microsurgical excision of lesion of rectum
+∞
14.7
14
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.7
14.7
76
270
JG1BG
NOMESCO Finland
MRI of rectum
159.6
14.6
15
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
17.2
14.2
22
14
JGA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in rectum
57.0
14.0
16
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
13.7
13
*
8140/2-C20.9
ICD-O-3
Adenocarcinoma in situ, NOS, of rectum, NOS
+∞
13.7
13
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
13.5
50
131
K62.1
ICD-10 Finland
Rectal polyp
18.7
12.7
19
11
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
12.6
84
356
D01.2
ICD-10 Finland
Carcinoma in situ: Rectum
+∞
12.6
12
*
C209, 8213, 2
ICD-O-3
NA
+∞
12.6
12
*
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
+∞
12.6
12
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
137.1
12.6
13
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.0
12.4
28
39
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
13.5
11.9
20
16
WZC30
NOMESCO Finland
Teaching
4.4
11.7
44
116
A04AA02
ATC
granisetron; systemic, transdermal
68.5
11.7
13
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
11.6
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.6
11
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
11.6
11
*
TJF80
NOMESCO Finland
Ostomy education
63.0
10.7
12
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
115.0
10.5
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.5
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.5
10
*
ZXC96
NOMESCO Finland
Robot assisted procedure
34.2
10.4
13
*
Z71.8
ICD-10 Finland
Other specified counselling
2.9
9.7
69
297
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
9.6
72
321
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
6.0
9.5
26
48
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
9.4
9
*
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
+∞
9.4
9
*
D75
ICPC
Malignant neoplasm colon/rectum
+∞
9.4
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.4
9
*
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
93.3
8.5
9
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.4
8.5
30
75
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.4
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
7.0
8.1
19
29
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
7.9
7.8
17
23
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
26.0
7.6
10
*
UJF30
NOMESCO Finland
Ileoscopy through colon
3.5
7.6
35
111
N02BE01
ATC
paracetamol; systemic, rectal
2.9
7.5
206
1694
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
4.7
7.4
24
55
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.3
7
*
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
+∞
7.3
7
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
7.0
39
142
WX306
NOMESCO Finland
Lumbar epidural anesthesy
6.0
6.9
18
32
L02AE02
ATC
leuprorelin; implant, parenteral
23.3
6.7
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.7
6.6
11
9
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
71.7
6.5
7
*
JN4CD
NOMESCO Finland
Very extensive body CT
8.5
6.4
13
16
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.5
6.3
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
6.1
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
157
118
31.70
184.21
6.1
1.3
12.9
5.2
ug/l
0.54
130
91
216
875
9.36
53.72
5.5
3.5
—
—
—
0
0
98
227
6.30
43.32
1.8
2.3
5.6
7.7
umol/l
1.04
87
195
203
906
6.51
41.05
7.7
3.4
34.5
35.7
g/l
2.22
198
842
81
182
5.99
36.41
1.9
2.0
34.4
31.6
u/l
0.36
69
153
128
448
4.63
33.37
3.7
2.0
—
—
—
0
0
204
1031
5.42
32.16
10.5
3.8
11.1
12.2
umol/l
1.15
199
968
209
1250
4.32
22.09
7.3
4.1
6.7
6.8
mmol/l
0.34
200
1167
82
282
3.78
20.44
3.1
2.3
21.5
23.5
%
0.53
74
244
89
327
3.61
20.03
3.2
2.8
0.9
1.3
e6/l
0.70
44
166
148
753
3.22
19.32
3.6
2.9
—
—
—
0
0
124
572
3.22
19.12
3.7
2.8
0.2
0.5
e6/l
1.34
86
420
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
63
6.05
18.13
3.0
2.3
0.3
0.4
u/ml
0.21
15
32
175
1008
3.22
17.94
9.7
5.4
1.2
1.2
mmol/l
2.36
148
871
116
540
3.06
17.22
2.3
2.1
2.7
2.9
mg/l
0.76
101
461
163
923
3.03
16.82
8.1
5.0
1.2
1.2
mmol/l
1.92
152
818
84
361
2.95
13.93
2.9
2.6
0.6
1.1
e6/l
1.59
39
202
175
1123
2.68
12.73
13.3
5.8
4.2
4.3
e9/l
0.17
145
982
195
1345
2.76
11.84
5.1
4.2
5107.8
711.3
e6/l
—
6
23
62
246
2.99
11.67
9.3
6.1
0.5
1.5
mmol/l
1.17
52
198
119
668
2.43
11.07
5.1
2.0
2.3
2.3
mmol/l
0.08
108
541
39
120
3.64
11.05
1.4
1.5
—
—
—
0
0
34
97
3.88
10.73
12.8
7.2
24.4
25.0
mmol/l
0.40
34
88
214
1607
2.81
9.93
4.5
4.1
16.0
12.6
mm/h
1.89
208
1455
252
2118
5.97
9.00
28.2
12.7
33.2
23.9
mg/l
3.97
241
1641
255
2252
5.95
8.69
34.5
15.7
139.5
139.8
mmol/l
0.87
255
2180
111
659
2.19
8.52
2.8
2.2
60.9
57.0
u/l
0.45
104
613
255
2257
5.86
8.51
35.2
15.8
4.0
4.0
mmol/l
1.63
255
2185
68
329
2.44
8.45
1.7
1.7
—
—
—
0
0
255
2260
5.80
8.33
35.2
15.3
89.4
81.8
umol/l
1.45
255
2260
58
263
2.55
8.26
7.0
4.8
1.0
1.0
mmol/l
0.39
53
238
20
47
4.52
8.09
1.8
1.5
—
—
—
0
0
50
213
2.67
8.07
4.7
2.9
—
—
—
0
0
255
2267
5.67
7.95
16.8
9.0
24.2
25.5
u/l
0.83
255
2169
14
24
6.11
7.94
1.5
1.2
—
—
—
0
0
146
992
2.07
7.60
4.0
3.6
0.0
0.0
estimate
0.00
38
157
241
2019
3.42
7.47
31.3
11.6
73.8
76.0
ml/min/173m2
0.85
205
1621
50
226
2.50
7.12
1.7
1.8
—
—
—
0
0
14
27
5.42
7.05
4.2
2.1
35.3
33.9
pg
0.82
14
27
50
227
2.49
7.05
1.7
1.8
—
—
—
0
0
144
994
2.00
6.96
5.5
5.0
0.0
0.0
estimate
0.00
43
154
126
832
1.99
6.90
2.4
2.2
79.9
77.2
nmol/l
0.45
114
726
33
126
2.85
6.52
1.3
1.7
—
—
—
0
0
144
1011
1.94
6.45
4.0
3.7
0.0
0.0
estimate
0.00
39
151
174
1317
1.96
6.07
4.0
3.0
60.7
50.1
u/l
0.75
161
1226
115
761
1.91
6.04
4.2
3.1
1942.9
1414.7
ng/l
0.73
105
651
13
27
5.01
6.04
3.2
1.6
3.8
4.8
e9/l
0.65
13
27
13
28
4.83
5.80
4.2
2.3
51.7
57.5
%
0.45
13
28
71
411
2.00
5.44
4.9
2.1
2.5
2.4
mmol/l
1.00
66
349
255
2344
4.29
5.24
43.2
18.9
127.4
136.9
g/l
16.18
255
2293
19
61
3.28
5.02
2.3
1.2
66.3
49.1
mg/l
0.42
13
51
19
61
3.28
5.02
2.3
1.2
59.6
35.5
mg/l
0.71
13
51
135
983
1.77
4.91
2.3
2.0
92.2
95.1
pmol/l
0.36
90
514
14
38
3.84
4.71
3.3
1.6
17.1
16.1
%
—
9
18
191
1581
1.77
4.05
4.4
3.6
15.4
15.0
pmol/l
1.13
173
1415
88
593
1.73
4.02
3.3
2.4
3488.3
9856.6
umol/l
0.89
77
513
78
508
1.76
4.02
1.8
1.7
460.0
437.8
pmol/l
0.23
66
419
17
59
3.01
3.98
2.4
1.2
—
0.8
—
0
5
84
562
1.73
3.93
1.8
1.6
19.4
20.4
nmol/l
0.28
78
477
73
472
1.76
3.84
3.8
3.8
276.3
347.8
ng/l
0.13
63
395
215
1862
1.86
3.68
35.3
13.8
37.8
39.9
%
3.84
157
1226
64
403
1.78
3.67
1.2
1.3
2.5
1.6
u/ml
0.30
19
120
14
46
3.16
3.58
1.3
1.6
—
—
—
0
0
7
9
7.95
3.58
3.1
1.2
—
—
—
0
0
81
550
1.68
3.54
3.7
2.6
0.7
0.8
ug/l
0.26
57
377
222
1965
1.85
3.23
5.4
4.5
2.0
2.6
mu/l
0.49
204
1761
10
28
3.67
3.23
1.4
1.3
109.5
58.1
pmol/l
—
10
28
139
1099
1.56
3.17
2.3
2.5
—
—
—
0
0
14
50
2.90
3.14
2.9
2.3
8.1
7.9
kpa
0.28
14
42
18
77
2.44
2.89
3.6
3.7
—
—
—
0
0
20
91
2.30
2.81
1.5
1.2
7.1
7.6
g/l
0.89
15
69
20
91
2.30
2.81
1.5
1.2
3.9
3.9
g/l
0.09
13
65
20
91
2.30
2.81
1.5
1.2
—
—
—
0
0
6
10
6.11
2.71
1.5
1.4
14.7
18.3
ug/l
—
6
10
9
25
3.69
2.60
4.2
1.8
3.3
150.7
u/ml
—
9
25
234
2140
1.87
2.58
4.9
5.0
5.9
6.0
mmol/l
0.90
220
1938
102
786
1.49
2.45
4.5
3.8
—
—
—
0
0
125
1004
1.47
2.43
5.5
4.0
2.0
2.1
ug/l
0.08
115
895
74
538
1.52
2.33
4.9
3.9
0.0
0.0
estimate
0.00
41
153
15
304
0.46
2.28
6.9
6.8
—
—
—
0
0
7
18
3.96
2.26
2.0
1.6
—
—
—
0
0
102
796
1.46
2.26
4.4
3.8
20.5
24.0
%
1.88
54
384
65
463
1.54
2.24
2.1
1.7
1079.9
1178.8
nmol/l
0.36
49
352
12
48
2.57
2.22
1.3
1.4
—
—
—
0
0
225
2057
1.66
2.19
6.8
6.5
40.0
40.4
mmol/mol
0.32
213
1899
11
43
2.63
2.12
1.5
1.6
—
—
—
0
0
13
56
2.39
2.08
1.7
1.3
—
—
—
0
0
11
44
2.57
2.04
1.8
1.4
—
—
—
0
0
16
78
2.12
1.95
1.1
1.1
—
—
—
0
0
7
22
3.24
1.89
1.0
1.0
—
—
—
0
0
20
108
1.92
1.87
6.0
3.8
23.2
24.4
mmol/l
0.68
20
96
9
35
2.63
1.82
1.9
1.4
—
—
—
0
0
9
36
2.55
1.75
1.2
1.3
—
—
—
0
0
9
36
2.55
1.75
1.2
1.3
—
—
—
0
0
5
13
3.90
1.72
2.4
1.3
—
—
—
0
0
7
25
2.85
1.66
2.0
1.4
—
—
—
0
0
33
217
1.60
1.61
6.5
3.4
0.6
1.9
mmol/l
0.72
27
176
234
2199
1.60
1.56
5.2
5.5
2.5
2.7
mmol/l
1.47
214
2009
61
461
1.42
1.55
4.5
1.7
2.5
1.1
mg/l
1.97
51
371
9
38
2.42
1.47
1.1
1.4
—
—
—
0
0
7
28
2.54
1.46
1.0
1.1
—
—
—
0
0
9
39
2.35
1.44
1.9
1.4
—
—
—
0
0
6
22
2.77
1.44
2.2
1.4
—
—
—
0
0
9
40
2.29
1.41
1.4
1.2
203.5
19.4
u/l
—
9
34
20
317
0.60
1.39
4.1
5.1
31.3
31.7
%
0.06
13
209
6
23
2.65
1.37
2.2
1.3
—
—
—
0
0
111
940
1.31
1.36
3.6
3.7
35.8
78.2
ng/l
0.61
87
685
6
25
2.43
1.25
1.2
1.4
—
—
—
0
0
6
26
2.34
1.19
1.5
1.2
—
—
—
0
0
6
26
2.34
1.19
1.5
1.1
—
—
—
0
0
11
58
1.94
1.14
5.4
2.6
24.8
24.7
mmol/l
0.02
11
47
7
33
2.15
1.06
1.4
1.2
—
—
—
0
0
6
27
2.25
0.94
1.3
1.2
—
—
—
0
0
225
2149
1.33
0.85
4.7
4.9
4.4
4.5
mmol/l
0.76
209
1969
8
47
1.72
0.81
1.5
1.2
—
—
—
0
0
21
148
1.46
0.81
4.0
3.7
5.1
5.0
kpa
0.05
21
138
5
96
0.51
0.80
1.6
1.5
—
—
—
0
0
0
27
0.00
0.78
0.0
1.0
—
—
—
0
0
0
27
0.00
0.78
0.0
3.3
—
29.8
—
0
9
83
722
1.22
0.75
2.1
2.1
101.8
315.0
u/l
1.34
78
672
5
25
2.02
0.73
1.6
1.2
—
—
—
0
0
222
2133
1.27
0.67
4.6
4.9
1.4
1.4
mmol/l
0.23
205
1949
215
2060
1.24
0.65
4.1
4.4
1.3
1.3
mmol/l
0.12
199
1871
18
129
1.42
0.65
1.4
1.4
—
—
—
0
0
13
87
1.52
0.64
1.5
1.6
—
—
—
0
0
5
29
1.74
0.64
1.2
1.2
195.4
302.7
pmol/l
—
5
24
12
79
1.54
0.63
1.4
1.4
—
—
—
0
0
69
600
1.20
0.62
1.6
1.7
1.3
1.4
mmol/l
0.15
59
497
5
30
1.68
0.61
1.0
1.1
364.4
255.3
u/ml
—
5
16
25
196
1.30
0.55
1.4
1.3
—
—
—
0
0
39
332
1.21
0.45
1.3
1.3
27.3
12.0
u/ml
0.35
15
112
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
5
31
1.62
0.43
1.0
1.4
—
181.9
—
0
11
0
15
0.00
0.41
0.0
2.1
—
59.2
—
0
10
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
22
180
1.24
0.37
6.0
2.8
5.1
4.4
kpa
0.60
22
169
23
190
1.23
0.36
2.6
1.6
420.8
359.8
nmol/l
1.22
23
174
7
53
1.33
0.31
1.3
1.6
—
—
—
0
0
21
249
0.83
0.30
1.0
1.3
—
—
—
0
0
5
42
1.19
0.21
1.2
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
17.6
—
0
11
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
8
105
0.75
0.21
1.4
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
7
60
1.17
0.18
1.4
1.4
—
—
—
0
0
38
356
1.08
0.12
1.4
1.3
16.8
35.2
iu/ml
1.92
14
114
5
45
1.11
0.10
1.2
1.1
—
—
—
0
0
5
47
1.07
0.09
1.0
1.1
—
—
—
0
0
16
147
1.09
0.07
1.1
1.3
—
50.4
—
0
11
15
141
1.07
0.03
1.7
1.8
—
—
—
0
0
12
113
1.06
0.02
1.4
1.2
90.2
117.1
iu/ml
—
7
38
11
117
0.94
0.02
5.8
2.5
1.1
1.2
%
0.14
11
117
9
89
1.01
0.00
1.3
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
7
79
0.88
0.00
1.4
2.2
40.3
41.7
u/l
—
7
67
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
17
170
1.00
0.00
4.6
2.0
46.4
61.5
ml/min/173m2
—
10
68
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1683.8
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
6
62
0.97
0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
63.2
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
28.1
—
0
5
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_INSITU_RECTUM_EXALLC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_INSITU_RECTUM_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_INSITU_RECTUM_EXALLC – Carcinoma in situ of rectum
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data